Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the ...

PharmaTher Holdings (CSE:PHRM) is on track to resubmit information to the U.S. Food and Drug Administration (FDA) by the end ...

At the University of Oklahoma, Prof. Indrajeet Sharma is leading a team of scientists that is working on a ‘skeletal editing’ ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Shares of Axsome Therapeutics ( AXSM 20.22%) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, ...

Prince Harry has lived in the US for over four years, but many questions have been raised as to the validity of his visa due ...

The AFLPA boss said the union would refuse to accept a new drug code regime of immediate fines. Also, players testing ...

Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...

US President Donald Trump has ruled out deporting Prince Harry from the United States, despite ongoing litigation questioning ...

They are important niches to the scientists who can now solve previously unsolvable problems, but they may not constitute ...

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided a ...